Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease.
about
Update on the use of topical NSAIDs for the treatment of soft tissue and musculoskeletal pain: a review of recent data and current treatment options.Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury.Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch.Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double-blind, placebo-controlled study.Clinical microdialysis in skin and soft tissues: an update.Diclofenac patch for topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study.Preliminary study on carprofen concentration measurements after transcutaneous treatment with Vetdrop® in a microfracture joint defect model in sheepTopical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studiesEfficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.A Mechanism-Based Approach to the Management of Osteoarthritis PainEvaluation of diclofenac prodrugs for enhancing transdermal delivery.Topical ketoprofen TDS patch versus diclofenac gel: efficacy and tolerability in benign sport related soft-tissue injuries.Modern management of mild-to-moderate joint pain due to osteoarthritis: a holistic approach.Topical therapies for osteoarthritis.Topical delivery of nonsteroidal anti-inflammatory drugs for osteoarthritis.Utility of Göttingen minipigs for Prediction of Human Pharmacokinetic Profiles After Dermal Drug Application.Skin penetration and tissue permeation after topical administration of diclofenac.A biologically active delivery material with dried-rehydrated vesicles containing the anti-inflammatory diclofenac for potential wound healing.Targeted drug delivery to the skin and deeper tissues: role of physiology, solute structure and disease.Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulationPharmacokinetic comparison of oral and local action transcutaneous flurbiprofen in healthy volunteers.Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation.Pharmacokinetics of Transdermal Etofenamate and Diclofenac in Healthy Volunteers.Deep tissue penetration of bases and steroids after dermal application in rat.The effect of ion-pair formation combined with penetration enhancers on the skin permeation of loxoprofen.Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model.
P2860
Q33632966-9A2D7BE2-61AA-4CCC-A1B4-C7E2C75D6828Q34322112-F7544798-B1C2-4F1C-A735-5FD4F173EE92Q34418290-CC7BAB29-2476-443B-98B0-C226B536AC59Q34555258-80E18D3D-7DCC-4896-9A17-2F50156C5C07Q34752069-A798D5D1-CC70-44A2-9A65-C466D00E106DQ35328456-DA3631EC-5F1D-417E-80A2-57D12962D6A7Q35502029-93890D82-8272-4693-B0C5-B405F68B3EAFQ35803097-4EA72B03-453F-489D-94D9-5F4D909973D6Q35954561-CDC8517E-FBA2-4D67-AAC7-6597BE060C5DQ36217637-EDABD1A6-3F54-4244-9E41-824AB0EFD306Q36635316-7F52CC8C-9B19-4281-A936-9C90B14E3552Q36767855-74A338D5-1E85-429C-ADF4-B0DB61C3B4DDQ37798321-AD49F347-ECB8-4227-B98C-DB8CC961C51DQ37902642-C665623A-54C6-4EAD-A59C-E3FCA5F8A219Q37997056-263C2D4B-F175-497F-8C44-00486572D6D4Q38614712-535D2EC2-D42E-401E-B631-EB2E7E413651Q38691566-B56B0E2F-B0B7-4629-9B9B-9BAE17CC7B48Q38814483-8953EC75-205D-4EDF-B8A7-AD481665E058Q41639071-8E367B8C-226B-4BD1-9B43-FF4F0865BB89Q41850972-3DAC74CA-ED1E-4556-82B9-0C4E813D3058Q42681117-BA73FDBF-549F-4B3E-A2D1-B2F94C2AA61AQ43679305-0CCA62F9-7485-468A-A2B6-797FB577CBC8Q50611260-63B08837-1CE4-4BE7-B0A4-4C0FBBAF2883Q51619145-F3F845DD-0058-405C-89B3-6F3C299AB00FQ53393894-4B0537A3-5F2B-430D-85DD-0C0605C9652AQ53799480-93D98BA7-6BF0-4F8E-B856-38BB0689116A
P2860
Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease.
description
1991 nî lūn-bûn
@nan
1991 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Diclofenac concentrations in s ...... nd degenerative joint disease.
@ast
Diclofenac concentrations in s ...... nd degenerative joint disease.
@en
Diclofenac concentrations in s ...... nd degenerative joint disease.
@nl
type
label
Diclofenac concentrations in s ...... nd degenerative joint disease.
@ast
Diclofenac concentrations in s ...... nd degenerative joint disease.
@en
Diclofenac concentrations in s ...... nd degenerative joint disease.
@nl
prefLabel
Diclofenac concentrations in s ...... nd degenerative joint disease.
@ast
Diclofenac concentrations in s ...... nd degenerative joint disease.
@en
Diclofenac concentrations in s ...... nd degenerative joint disease.
@nl
P2093
P2860
P1476
Diclofenac concentrations in s ...... nd degenerative joint disease.
@en
P2093
Frölich JC
Lustinetz T
Radermacher J
P2860
P304
P356
10.1111/J.1365-2125.1991.TB05576.X
P407
P577
1991-05-01T00:00:00Z